The role of murine models of prostate cancer in drug target discovery and validation

Neamine Inhibits Prostate Cancer Growth by Suppressing Angiogenin-Mediated rRNA Transcription

(2009) S. Ibaragi et al.   CLINICAL CANCER RESEARCH

Effective Prostate Cancer Chemopreventive Intervention with Green Tea Polyphenols in the TRAMP Model Depends on the Stage of the Disease

(2009) V. M. Adhami et al.   CLINICAL CANCER RESEARCH

Silibinin Suppresses Growth of Human Prostate Carcinoma PC-3 Orthotopic Xenograft via Activation of Extracellular Signal-Regulated Kinase 1/2 and Inhibition of Signal Transducers and Activators of Transcription Signaling

(2009) R. P. Singh et al.   CLINICAL CANCER RESEARCH

Stage-Specific Inhibitory Effects and Associated Mechanisms of Silibinin on Tumor Progression and Metastasis in Transgenic Adenocarcinoma of the Mouse Prostate Model

(2008) K. Raina et al.   CANCER RESEARCH

Silibinin Inhibits Established Prostate Tumor Growth, Progression, Invasion, and Metastasis and Suppresses Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Transgenic Adenocarcinoma of the Mouse Prostate Model Mice

(2008) R. P. Singh et al.   CLINICAL CANCER RESEARCH

Advances in mouse models of prostate cancer

(2008) Imran Ahmad et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

PTEN Knockout Prostate Cancer as a Model for Experimental Immunotherapy

(2008) Kazunori Haga et al.   JOURNAL OF UROLOGY

Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma

(2008) C. K. Ratnacaram et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA